ADVFN US – Market Content Editor

Vermilion Energy Inc. (NYSE:VET) reported mixed fourth-quarter results on Wednesday, with earnings falling short of expectations even as revenue came in well above forecasts. The company posted a loss of Cdn$2.86 per share for the quarter, far below the analyst consensus estimate of earnings of Cdn$0.30 per share. However, revenue reached Cdn$458.72 million, beating the…

IREN (NASDAQ:IREN) shares declined about 4.2% to $42 in premarket trading Thursday after the company unveiled plans for an at-the-market equity program that could raise up to $6 billion. The offering will be managed by a syndicate of 11 banks, including Goldman Sachs, JPMorgan and Citigroup. According to the company’s prospectus, IREN had roughly 332.3…

PepGen Inc. (NASDAQ:PEPG) reported a narrower-than-expected fourth-quarter loss on Thursday, but the stock plunged about 20% in after-hours trading as investors focused on regulatory concerns surrounding one of its key trials. The company posted a quarterly loss of $0.27 per share, beating analyst estimates of $0.37 per share. Despite the earnings surprise, shares fell sharply…

Victoria’s Secret & Co (NYSE:VSCO) reported fourth-quarter results that exceeded Wall Street expectations and issued an optimistic forecast, but the company’s shares declined in premarket trading. The retailer posted earnings per share of $2.77 for the fourth quarter, surpassing analysts’ forecasts of $2.47. Revenue reached $2.27 billion, also topping the consensus estimate of $2.22 billion.…

Distribution Solutions Group (NASDAQ:DSGR) reported fourth-quarter results that fell short of Wall Street expectations, with weaker profitability despite stable revenue. Sales for the quarter totaled $481.6 million, essentially flat from a year earlier and below analysts’ estimates of $496.3 million. Adjusted earnings per share came in at $0.18, significantly under the consensus forecast of $0.32.…

Helus Pharma (NASDAQ:HELP) reported positive topline Phase 2 signal-detection results for its investigational therapy HLP004 in adults with moderate-to-severe generalized anxiety disorder (GAD) who remained symptomatic despite standard antidepressant treatment. The study enrolled 36 patients who received two intramuscular doses of HLP004 or placebo, administered three weeks apart while continuing their existing standard-of-care therapy. Patients…

Medicus Pharma (NASDAQ:MDCX) said its SkinJect microneedle therapy showed encouraging results in a Phase 2 study evaluating the treatment for nodular basal cell carcinoma. The SKNJCT-003 trial tested the company’s Doxorubicin Microneedle Array, a non-invasive therapy designed to treat skin cancer. In the 200-microgram dose cohort at Day 57, the treatment achieved 73% clinical clearance…

Palladyne AI Corp (NASDAQ:PDYN) reported fourth-quarter and full-year 2025 results, pointing to a year of strategic transformation driven by acquisitions and expansion into defense and aerospace technologies. The company said its purchases of GuideTech, Warnke Precision Machining and MKR Fabricators in November 2025, alongside the launch of Palladyne Defense, marked a shift from a pure…

Fusion Fuel Green (NASDAQ:HTOO) said its indirectly held subsidiary Al Shola Al Modea Gas Distribution has been awarded two engineering subcontracts in Dubai valued at about $1.16 million. The contracts cover the design, supply, installation, testing and commissioning of centralized LPG systems across multiple buildings within two residential developments in the United Arab Emirates. Work…